Table:
begin	end	state
1	26	signal peptide
27	230	non-cytoplasmic
231	254	transmembrane
255	261	cytoplasmic
262	280	transmembrane
281	285	non-cytoplasmic
286	306	transmembrane
307	317	cytoplasmic
318	337	transmembrane
338	368	non-cytoplasmic
369	387	transmembrane
388	417	cytoplasmic
418	437	transmembrane
438	452	non-cytoplasmic
453	478	transmembrane
479	484	cytoplasmic
485	503	transmembrane
504	520	non-cytoplasmic

Input:
>WP_028488590.1 NCBI__GCF_000621325.1:WP_028488590.1
MLKTHDLPRIFLLSLLLWFSPLLQAEQESAAFTQAAALFAEASFDKTGEAIDLLAASGDP
EVVPYLQALLDGKLYQHEEQGTLVIVADGASTDGLRKIPTKNSLRRSLRAAIGQLSLSSP
DASVRLTSANGLLETITPDMAPQLRGLLDKETDPAVQEALSLGLAMADLNAAEQPVRLAA
IASLAGNLNPGVRNRLTTMTTDSDAAVAKAAQASLKAIEDRAELYGYAETLFFGLSLGSV
LVLAAIGLAITFGVMGVINMAHGELIMLGAYTTYIVQQLMPQAIDYSLFVAVPAAFIVSG
LMGILIERTVIRHLYGRPLETLLATFGISLILQQLVRTVISPQNVPVSNPSWMSGSLEIN
SVLSLTYNRLYIVLFCLMVFALLYFVLRKTNLGLQVRAVSQNRAMARAMGVRSARVDALT
FGLGSGIAGVAGVALSQLTNVGPNLGQSYIIDSFMVVVFGGVGNLWGTLVAGLSLGVVNK
VLEPWAGAVLAKILVLVFIILFIQKRPRGLFPQKGRAAGD

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server